Literature DB >> 21496969

[New drugs policy: safety and quality].

Ester Amado Guirado, Laura Diego, Rosa Madridejos Mora.   

Abstract

Mesh：

Year:  2011        PMID： 21496969      PMCID： PMC7024939          DOI： 10.1016/j.aprim.2011.02.004

Source DB:  PubMed          Journal:  Aten Primaria        ISSN： 0212-6567            Impact factor:   1.137


× No keyword cloud information.
  5 in total

1.  Using market-exclusivity incentives to promote pharmaceutical innovation.

Authors:  Aaron S Kesselheim
Journal:  N Engl J Med       Date:  2010-11-04       Impact factor: 91.245

2.  Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions.

Authors:  Diane K Wysowski; Lynette Swartz
Journal:  Arch Intern Med       Date:  2005-06-27

Review 3.  New drugs from old.

Authors: 
Journal:  Drug Ther Bull       Date:  2006-10

Review 4.  Lessons from 60 years of pharmaceutical innovation.

Authors:  Bernard Munos
Journal:  Nat Rev Drug Discov       Date:  2009-12       Impact factor: 84.694

5.  A look back at 2009: one step forward, two steps back.

Authors: 
Journal:  Prescrire Int       Date:  2010-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.